182 related articles for article (PubMed ID: 21116286)
21. Sphingolipid/Ceramide Pathways and Autophagy in the Onset and Progression of Melanoma: Novel Therapeutic Targets and Opportunities.
Lai M; La Rocca V; Amato R; Freer G; Pistello M
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336922
[TBL] [Abstract][Full Text] [Related]
22. Altering Sphingolipid Metabolism Attenuates Cell Death and Inflammatory Response After Myocardial Infarction.
Hadas Y; Vincek AS; Youssef E; Żak MM; Chepurko E; Sultana N; Sharkar MTK; Guo N; Komargodski R; Kurian AA; Kaur K; Magadum A; Fargnoli A; Katz MG; Hossain N; Kenigsberg E; Dubois NC; Schadt E; Hajjar R; Eliyahu E; Zangi L
Circulation; 2020 Mar; 141(11):916-930. PubMed ID: 31992066
[TBL] [Abstract][Full Text] [Related]
23. Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-κB-dependent P-glycoprotein upregulation.
Tan SF; Dunton W; Liu X; Fox TE; Morad SAF; Desai D; Doi K; Conaway MR; Amin S; Claxton DF; Wang HG; Kester M; Cabot MC; Feith DJ; Loughran TP
J Lipid Res; 2019 Jun; 60(6):1078-1086. PubMed ID: 30962310
[TBL] [Abstract][Full Text] [Related]
24. Autophagy augmentation alleviates cigarette smoke-induced CFTR-dysfunction, ceramide-accumulation and COPD-emphysema pathogenesis.
Bodas M; Pehote G; Silverberg D; Gulbins E; Vij N
Free Radic Biol Med; 2019 Feb; 131():81-97. PubMed ID: 30500419
[TBL] [Abstract][Full Text] [Related]
25. Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways.
Hajj C; Becker-Flegler KA; Haimovitz-Friedman A
Biol Chem; 2015 Jun; 396(6-7):669-79. PubMed ID: 25719313
[TBL] [Abstract][Full Text] [Related]
26. Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate.
Mao C; Obeid LM
Biochim Biophys Acta; 2008 Sep; 1781(9):424-34. PubMed ID: 18619555
[TBL] [Abstract][Full Text] [Related]
27. Acid Ceramidase: A Novel Therapeutic Target in Cancer.
Vijayan Y; Lankadasari MB; Harikumar KB
Curr Top Med Chem; 2019; 19(17):1512-1520. PubMed ID: 30827244
[TBL] [Abstract][Full Text] [Related]
28. Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity.
Realini N; Solorzano C; Pagliuca C; Pizzirani D; Armirotti A; Luciani R; Costi MP; Bandiera T; Piomelli D
Sci Rep; 2013; 3():1035. PubMed ID: 23301156
[TBL] [Abstract][Full Text] [Related]
29. Increasing intracellular ceramide: an approach that enhances the cytotoxic response in prostate cancer cells.
Wang H; Charles AG; Frankel AJ; Cabot MC
Urology; 2003 May; 61(5):1047-52. PubMed ID: 12736045
[TBL] [Abstract][Full Text] [Related]
30. Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications.
Morad SA; Cabot MC
Biochim Biophys Acta; 2015 Sep; 1851(9):1134-45. PubMed ID: 25964209
[TBL] [Abstract][Full Text] [Related]
31. Complete Acid Ceramidase ablation prevents cancer-initiating cell formation in melanoma cells.
Lai M; Realini N; La Ferla M; Passalacqua I; Matteoli G; Ganesan A; Pistello M; Mazzanti CM; Piomelli D
Sci Rep; 2017 Aug; 7(1):7411. PubMed ID: 28785021
[TBL] [Abstract][Full Text] [Related]
32. Regulation of alkaline ceramidase activity by the c-Src-mediated pathway.
Sasaki H; Toyomura K; Matsuzaki W; Okamoto A; Yamaguchi N; Nakamura H; Murayama T
Arch Biochem Biophys; 2014 May; 550-551():12-9. PubMed ID: 24708996
[TBL] [Abstract][Full Text] [Related]
33. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
[TBL] [Abstract][Full Text] [Related]
34. Targeting ceramide metabolic pathway induces apoptosis in human breast cancer cell lines.
Vethakanraj HS; Babu TA; Sudarsanan GB; Duraisamy PK; Ashok Kumar S
Biochem Biophys Res Commun; 2015 Aug; 464(3):833-9. PubMed ID: 26188095
[TBL] [Abstract][Full Text] [Related]
35. Modulation of ceramide metabolism enhances viral protein apoptin's cytotoxicity in prostate cancer.
Liu X; Elojeimy S; El-Zawahry AM; Holman DH; Bielawska A; Bielawski J; Rubinchik S; Guo GW; Dong JY; Keane T; Hannun YA; Tavassoli M; Norris JS
Mol Ther; 2006 Nov; 14(5):637-46. PubMed ID: 16887394
[TBL] [Abstract][Full Text] [Related]
36. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
Batra S; Reynolds CP; Maurer BJ
Cancer Res; 2004 Aug; 64(15):5415-24. PubMed ID: 15289350
[TBL] [Abstract][Full Text] [Related]
37. Targeting inhibitor 2 of protein phosphatase 2A as a therapeutic strategy for prostate cancer treatment.
Mukhopadhyay A; Tabanor K; Chaguturu R; Aldrich JV
Cancer Biol Ther; 2013 Oct; 14(10):962-72. PubMed ID: 24025258
[TBL] [Abstract][Full Text] [Related]
38. The molecular medicine of acid ceramidase.
Frohbergh M; He X; Schuchman EH
Biol Chem; 2015 Jun; 396(6-7):759-65. PubMed ID: 25938220
[TBL] [Abstract][Full Text] [Related]
39. Functions of neutral ceramidase in the Golgi apparatus.
Sakamoto W; Coant N; Canals D; Obeid LM; Hannun YA
J Lipid Res; 2018 Nov; 59(11):2116-2125. PubMed ID: 30154232
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death.
Strelow A; Bernardo K; Adam-Klages S; Linke T; Sandhoff K; Krönke M; Adam D
J Exp Med; 2000 Sep; 192(5):601-12. PubMed ID: 10974027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
